Altimmune, Inc. (NASDAQ:ALT) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Rich Eisenstadt - Chief Financial Officer Vipin Garg - Chief Executive Officer Scott Harris - Chief Medical Officer Scot Roberts - Chief Scientific Officer Conference Call Participants Seamus Fernandez - Guggenheim Securities Yasmeen Rahimi - Piper Sandler Corinne Jenkins - Goldman Sachs Roger Song - Jefferies Liisa Bayko - Evercore ISI Mayank Mamtani - B. Riley Jonathan Wolleben - JMP Securities Patri ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share ALT The NASDAQ Global Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition p ...

Altimmune Inc. (NASDAQ:ALT) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Vipin Garg - President, Chief Executive Officer Richard Eisenstadt - Chief Financial Officer Scott Harris - Chief Medical Officer Scot Roberts - Chief Scientific Officer Conference Call Participants Seamus Fernandez - Guggenheim Securities Yasmeen Rahimi - Piper Sandler Roger Song - Jefferies Corrine Jenkins - Goldman Sachs Mayank Mamtani - B. Riley Jon Wolleben - JMP Securities Joe Pantginis - HC ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-32587 ALTIMMUNE, INC. (Exact name of registrant as specified in its charter) Identification No.) (I.R.S.Employer T ...

Altimmune, Inc. (NASDAQ:ALT) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Richard Eisenstadt - CFO Vipin Garg - President & CEO Scot Roberts - Chief Scientific Officer Scott Harris - Chief Medical Officer Conference Call Participants Seamus Fernandez - Guggenheim Yasmeen Rahimi - Piper Sandler Liisa Bayko - Evercore ISI Mayank Mamtani - B. Riley Jon Wolleben - JMP Securities Operator Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Third Quarter Financ ...

Altimmune, Inc. (NASDAQ:ALT) Q2 2022 Results Conference Call August 11, 2022 8:30 AM ET Company Participants Richard Eisenstadt - Chief Financial Officer Vipin Garg - President and Chief Executive Officer Scot Roberts - Chief Scientific Officer Scott Harris - Chief Medical Officer Conference Call Participants Seamus Fernandez - Guggenheim Yasmeen Rahimi - Piper Sandler Roger Song - Jefferies Mayank Mamtani - B. Riley Jon Welandon - JMP Securities Patrick Trucchio - H.C. Wainwright Operator Good day, ladies ...